Security key
03835T309
Aptose Biosciences Inc. - Common Shares (APTO)
CUSIP: 03835T309
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 2,587,950
- Total 13F shares
- 2,708,592
- Share change
- +1,723,342
- Total reported value
- $2,055,953
- Price per share
- $0.76
- Number of holders
- 21
- Value change
- +$1,284,637
- Number of buys
- 4
- Number of sells
- 7
Report period
Q2 2024
Institutions
21
Top holders
10
APTO full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Aptose Biosciences Inc. SEC filings
Aptose Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03835T309
Recent filing periods:
Top shareholders of APTO - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Donald R. Wilson Jr. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,892,437
|
$12,885,141 | — | 03 Aug 2021 | |
| DRW Securities, LLC |
13F
|
Company |
23%
|
592,829
|
$984,096 | — | 31 Mar 2024 | |
| Sigma Planning Corp |
13F
|
Company |
7.2%
|
186,417
|
$309,452 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.4%
|
88,540
|
$146,976 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
33,893
|
$56,262 | — | 31 Mar 2024 | |
| Annandale Capital, LLC |
13F
|
Company |
1%
|
26,666
|
$44,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.99%
|
25,691
|
$42,647 | — | 31 Mar 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.82%
|
21,322
|
$35,395 | — | 31 Mar 2024 | |
| Bernd R. Seizinger |
3/4/5
|
Director |
—
mixed-class rows
|
20,333
mixed-class rows
|
$24,633 | — | 05 Feb 2024 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
0.48%
|
12,448
|
$20,664 | — | 31 Mar 2024 | |
| PDS Planning, Inc |
13F
|
Company |
0.39%
|
10,000
|
$16,600 | — | 31 Mar 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.28%
|
7,345
|
$15,351 | — | 31 Mar 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0.08%
|
2,020
|
$3,353 | — | 31 Mar 2024 | |
| Gleason Group, Inc. |
13F
|
Company |
0.05%
|
1,216
|
$2,019 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.04%
|
1,032
|
$2,000 | — | 31 Mar 2024 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.03%
|
832
|
$1,381 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
420
|
$697 | — | 31 Mar 2024 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.01%
|
300
|
$498 | — | 31 Mar 2024 | |
| Beaird Harris Wealth Management, LLC |
13F
|
Company |
0.01%
|
250
|
$415 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
133
|
$221 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
102
|
$219 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
115
|
$191 | — | 31 Mar 2024 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0%
|
92
|
$153 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
72
|
$120 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
66
|
$110 | — | 31 Mar 2024 | |
| Pacific Capital Wealth Advisors, Inc. |
13F
|
Company |
0%
|
6
|
$10 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2024 | |
| Jotin Marango |
3/4/5
|
Senior VP, CFO, and CBO |
—
class O/S missing
|
600,000
|
— | — | 18 Jan 2022 | |
| Fletcher Payne |
3/4/5
|
Sr VP and CFO |
—
class O/S missing
|
55,000
|
— | — | 05 Feb 2024 | |
| Caroline M. Loewy |
3/4/5
|
Former Director |
—
class O/S missing
|
50,000
|
— | — | 31 May 2022 | |
| Rafael Bejar |
3/4/5
|
Sr VP & Chief Medical Officer |
—
class O/S missing
|
35,000
|
— | — | 05 Feb 2024 | |
| Philippe Ledru |
3/4/5
|
Former Officer |
—
class O/S missing
|
11,000
|
— | — | 23 Feb 2024 | |
| Carol Gail Ashe |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
— | — | 05 Feb 2024 | |
| Denis R. Burger |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
— | — | 05 Feb 2024 | |
| Erich Platzer |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
— | — | 05 Feb 2024 | |
| Mark D. Vincent |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
— | — | 05 Feb 2024 | |
| Warren Whitehead |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
— | — | 05 Feb 2024 |
Institutional Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q2 2024
As of 30 Jun 2024,
Aptose Biosciences Inc. - Common Shares (APTO) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,708,592 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, DRW Securities, LLC, Sigma Planning Corp, Nantahala Capital Management, LLC, MORGAN STANLEY, Cetera Investment Advisers, Texas Capital Bank Wealth Management Services Inc, PDS Planning, Inc, TD Waterhouse Canada Inc., and ORG Partners LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
20
Q2 2024 holders
21
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.